Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J S Reis Filho

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
British Journal of Cancer|November 30, 2006
Microarray-based comparative genomic hybridisation of breast cancer patients receiving neoadjuvant chemotherapyJ-Y Pierga, J S Reis-Filho, S J Cleator, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 18, 2021
ESMO recommendations on the standard methods to detect RET fusions and mutations in daily practice and clinical researchC Belli, F Penault-Llorca, M Ladanyi, et al.
The Journal of Pathology|May 20, 2008
Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breastC Marchiò, M Iravani, R Natrajan, et al.
Breast Cancer Research and Treatment|April 7, 2009
A validated gene expression profile for detecting clinical outcome in breast cancer using artificial neural networksL J Lancashire, D G Powe, J S Reis-Filho, et al.
British Journal of Cancer|August 27, 2009
Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomasO Martinho, A Longatto-Filho, M B K Lambros, et al.
British Journal of Cancer|October 19, 2013
DICER1 hotspot mutations in non-epithelial gonadal tumoursL Witkowski, J Mattina, S Schönberger, et al.
Oncogene|March 21, 2017
Compromised BRCA1-PALB2 interaction is associated with breast cancer riskT K Foo, M Tischkowitz, S Simhadri, et al.
The Journal of Pathology|July 11, 2006
Array CGH profiling of favourable histology Wilms tumours reveals novel gains and losses associated with relapseR Natrajan, R D Williams, S N Hing, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2015
Response to dual HER2 blockade in a patient with HER3-mutant metastatic breast cancerF-C Bidard, C K Y Ng, P Cottu, et al.
Oncogene|January 22, 2013
Integrative molecular and functional profiling of ERBB2-amplified breast cancers identifies new genetic dependenciesK-K Shiu, D Wetterskog, A Mackay, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
British Journal of Cancer|November 30, 2006
Microarray-based comparative genomic hybridisation of breast cancer patients receiving neoadjuvant chemotherapyJ-Y Pierga, J S Reis-Filho, S J Cleator, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 18, 2021
ESMO recommendations on the standard methods to detect RET fusions and mutations in daily practice and clinical researchC Belli, F Penault-Llorca, M Ladanyi, et al.
The Journal of Pathology|May 20, 2008
Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breastC Marchiò, M Iravani, R Natrajan, et al.
Breast Cancer Research and Treatment|April 7, 2009
A validated gene expression profile for detecting clinical outcome in breast cancer using artificial neural networksL J Lancashire, D G Powe, J S Reis-Filho, et al.
British Journal of Cancer|August 27, 2009
Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomasO Martinho, A Longatto-Filho, M B K Lambros, et al.
British Journal of Cancer|October 19, 2013
DICER1 hotspot mutations in non-epithelial gonadal tumoursL Witkowski, J Mattina, S Schönberger, et al.
Oncogene|March 21, 2017
Compromised BRCA1-PALB2 interaction is associated with breast cancer riskT K Foo, M Tischkowitz, S Simhadri, et al.
The Journal of Pathology|July 11, 2006
Array CGH profiling of favourable histology Wilms tumours reveals novel gains and losses associated with relapseR Natrajan, R D Williams, S N Hing, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2015
Response to dual HER2 blockade in a patient with HER3-mutant metastatic breast cancerF-C Bidard, C K Y Ng, P Cottu, et al.
Oncogene|January 22, 2013
Integrative molecular and functional profiling of ERBB2-amplified breast cancers identifies new genetic dependenciesK-K Shiu, D Wetterskog, A Mackay, et al.
Pageof 10